Skip to content
← Full study record

NCT02994784 · MORE INFO

Limitations, agreements, and source contact

Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients · Source last updated 2023-05-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Study was halted early resulting in relatively small numbers of participants analyzed.
point Of Contact
email
mark.sloan@bmc.org
organization
Boston Medical Center and BU School of Medicine
phone
617-638-7519
title
John M Sloan, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Study was halted early resulting in relatively small numbers of participants analyzed.
point Of Contact
email
mark.sloan@bmc.org
organization
Boston Medical Center and BU School of Medicine
phone
617-638-7519
title
John M Sloan, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice